CME: Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease

Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease

Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease

IBD can be difficult to manage, especially when combined with iron deficiency anemia. Fortunately, there are therapies and resources that can help.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    As the most common extraintestinal complication from IBD, iron deficiency anemia (IDA) can take a heavy toll on your patients’ quality of life. This activity will review those impacts, in addition to discussing the different therapies and resources that are available to both you and your IBD patients.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.


    Bincy P. Abraham, MD, MS
    Associate Professor of Clinical Medicine
    Weill-Cornell – Houston Methodist
    Houston, TX

    Dr. Abraham receives consulting fees from AbbVie, Janssen, Pfizer, Samsung BioLogics, Takeda, and UCB; and conducts contracted research from Janssen and Takeda.

    Jason Ken Hou, MD, MS, FACG
    Assistant Professor Medicine-Gastroenterology
    Director, GI & Hepatology Fellowship Program
    Director of Research, IBD
    Baylor College of Medicine
    Staff Physician – Gastroenterology
    Medical Director, IBD
    Michael E. DeBakey VA Medical Center
    Houston, Texas

    Dr. Hou receives consulting fees and is a speaker for fromAbbVie, Janssen, and Pfizer; and conducts contracted research with AbbVie, Celgene, Genetech, Janssen, Pfizer, Redhill Biopharma, and Shield.

    Siddharth Singh, MD
    Assistant Professor of Clinical Medicine
    University of California San Diego
    Department of Medicine
    La Jolla, CA

    Dr. Singh receives consulting fees from AbbVie, AMAG Pharmaceuticals, and Takeda; and conducts contracted research from AbbVie, and Pfizer.

    Reviewers/Content Planners/Authors:

    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Ashley Rosenthal has nothing to disclose.
    • Sudha Sarode, MSPH has nothing to disclose.
    • Robert Schneider has nothing to disclose. 
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Clearly define the impact of IDA on the quality of life of patients with IBD
    • Clearly and capably identify the need to assess all patients with IBD for IDA
    • Identify the risks and benefits of using iron deficiency anemia therapies in patients with IBD and IDA
    • Engage IBD patients with anemia or IDA in managing their healthcare by implementing effective shared decision-making strategies
  • Target Audience

    This activity is designed to meet the educational needs of Gastroenterologists; Primary Care Physicians who manage patients with IBD; Nurse Practitioners and Physician Assistants in Gastroenterology.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Omnia-Prova Education Collaborative (TOPEC) and Crohn’s & Colitis Foundation. TOPEC is accredited by the ACCME to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    ReachMD Healthcare Image

    Prova Education, designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research. 

    In Collaboration with:
    ReachMD Healthcare Image

    The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals.  The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.

  • Commercial Support

    This activity is supported by an independent educational grant from AMAG Pharmaceuticals Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments


We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free